Conversely, in pathological conditions such as leukemia, malignant cells can exploit normal signaling pathways (like leptin-JAK/STAT or CXCL12-CXCR4) to favor an adipocyte-rich, tumor-supportive niche. Here, LEP is linked to neoplasm.